Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Communicable Diseases Intelligence (2018)
|
March 18, 2019
The use of normal human immunoglobulin (NHIG) for public health purposes in Queensland 2004-2014 and Australia 2014-2016
Megan K Young, Allan W Cripps, Graeme R Nimmo
Emerging Infectious Diseases
|
April 15, 2005
Staphylococcus aureus bacteremia, Australia
Peter Collignon, Graeme R Nimmo, Thomas Gottlieb, et al.
The Medical Journal of Australia
|
May 10, 2002
Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in south-east Queensland
Wendy J Munckhof, Jacqueline Harper, Jacqueline Schooneveldt, et al.
The Journal of Antimicrobial Chemotherapy
|
April 10, 2010
Escherichia coli ST131 producing CTX-M-15 in Australia
Hanna E Sidjabat, Petra Derrington, Graeme R Nimmo, et al.
Journal of Medical Virology
|
February 22, 2007
Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection
Robert Gibb, Graeme R Nimmo, Peter O'Loughlin, et al.
Journal of Clinical Microbiology
|
May 8, 2004
mecA Locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone
Flavia Huygens, Alex J Stephens, Graeme R Nimmo, et al.
Infection Control and Hospital Epidemiology
|
February 8, 2013
Spatial analysis of community-onset Staphylococcus aureus bacteremia in Queensland, Australia
John Marquess, Wenbiao Hu, Graeme R Nimmo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 5, 2020
Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure
Megan K Young, Shu-Kay Ng, Graeme R Nimmo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 6, 2018
The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended
Megan K Young, Shu-Kay Ng, Graeme R Nimmo, et al.
Pathology
|
July 17, 2013
Typing early Australian healthcare-associated MRSA: confirmation of major clones and emergence of ST1-MRSA-IV and novel ST2249-MRSA-III
John F Lancashire, Anna Jones, Haakon Bergh, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Communicable Diseases Intelligence (2018)
|
March 18, 2019
The use of normal human immunoglobulin (NHIG) for public health purposes in Queensland 2004-2014 and Australia 2014-2016
Megan K Young, Allan W Cripps, Graeme R Nimmo
Emerging Infectious Diseases
|
April 15, 2005
Staphylococcus aureus bacteremia, Australia
Peter Collignon, Graeme R Nimmo, Thomas Gottlieb, et al.
The Medical Journal of Australia
|
May 10, 2002
Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in south-east Queensland
Wendy J Munckhof, Jacqueline Harper, Jacqueline Schooneveldt, et al.
The Journal of Antimicrobial Chemotherapy
|
April 10, 2010
Escherichia coli ST131 producing CTX-M-15 in Australia
Hanna E Sidjabat, Petra Derrington, Graeme R Nimmo, et al.
Journal of Medical Virology
|
February 22, 2007
Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection
Robert Gibb, Graeme R Nimmo, Peter O'Loughlin, et al.
Journal of Clinical Microbiology
|
May 8, 2004
mecA Locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the Western Samoan phage pattern clone
Flavia Huygens, Alex J Stephens, Graeme R Nimmo, et al.
Infection Control and Hospital Epidemiology
|
February 8, 2013
Spatial analysis of community-onset Staphylococcus aureus bacteremia in Queensland, Australia
John Marquess, Wenbiao Hu, Graeme R Nimmo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 5, 2020
Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure
Megan K Young, Shu-Kay Ng, Graeme R Nimmo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 6, 2018
The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended
Megan K Young, Shu-Kay Ng, Graeme R Nimmo, et al.
Pathology
|
July 17, 2013
Typing early Australian healthcare-associated MRSA: confirmation of major clones and emergence of ST1-MRSA-IV and novel ST2249-MRSA-III
John F Lancashire, Anna Jones, Haakon Bergh, et al.
Page
of 11